We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01519362
First Posted: January 26, 2012
Last Update Posted: January 26, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Duo Zhang, First Hospital of Jilin University
January 24, 2012
January 26, 2012
January 26, 2012
October 2011
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis
Not Provided
Polyacrylamide hydrogel (PAAG) has been used as an injectable filler for soft tissue augmentation in different parts of the body , such as face, breast , or even penis for more than a decade . However, there are never reports about the application of a large amount of PAAG in epicranial aponeurosis to change the contour of the upper cranium accompanied with leukocytopenia. This fancy application turned out to be a disaster for the women who suffered from leukocytopenia , widespread migration of PAAG, recurrent swelling of the affected tissues and temporal pain changing with the temperature and the facial expression .
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
A 50-year-old lady had PAAG injected into her bilateral temporal epicranial aponeurosis for augmentation
Complication
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1
Not Provided
Not Provided

Inclusion Criteria:

  • PAAG injected into bilateral temporal epicranial aponeurosis

Exclusion Criteria:

  • PAAG injected into other parts of the body
Sexes Eligible for Study: Female
50 Years to 50 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01519362
zhangduo
No
Not Provided
Not Provided
Duo Zhang, First Hospital of Jilin University
Duo Zhang
Not Provided
Not Provided
First Hospital of Jilin University
January 2012